Alglucosidase alfa: 5 years of experience in late-onset Pompe disease

Benzer Materyaller

• Enzyme replacement therapy with alglucosidase alfa in Pompe disease: Clinical experience with rate escalation
  Yazar:: Desai, Ankit K., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?
  Yazar:: Lachmann, Robin, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• ALGLUCOSIDASE ALFA — A NEW STAGE IN THE THERAPY OF INFANTILE POMPE DISEASE
  Yazar:: E. N. Basargina, ve diğerleri
  Baskı/Yayın Bilgisi: (2014-09-01)
• Alglucosidase alfa: Long term use in the treatment of patients with Pompe disease
  Yazar:: Beck, Michael
  Baskı/Yayın Bilgisi: (2009)
• Earlier and higher dosing of alglucosidase alfa improve outcomes in patients with infantile-onset Pompe disease: Evidence from real-world experiences
  Yazar:: Chien, Yin-Hsiu, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)